Working… Menu
Trial record 6 of 15 for:    psvt

Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03464019
Recruitment Status : Recruiting
First Posted : March 13, 2018
Last Update Posted : April 26, 2021
Medpace, Inc.
IQVIA Biotech
Information provided by (Responsible Party):
Milestone Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022